Gelteq Ltd
GELS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001920092
No open-market purchases or sales by Gelteq Ltd insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $73.3K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +1 vs. previous quarter
- 6
- 13F valueReported value at the end of Q2 2026
- $73.3K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding GELS, Q2 2026
No superinvestor reported holding GELS at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Gelteq Ltd insiders from Form 4, newest first.
No open-market purchases or sales by Gelteq Ltd insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Gelteq Ltd at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Two Sigma Securities, LLC | 33,238 | $22.3K | 0.00% | +33,238 | New |
| Jane Street Group, LLC | 30,161 | $20.2K | 0.00% | +30,161 | New |
| Wedbush Securities Inc | 20,000 | $13.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 15,000 | $10.1K | 0.00% | +15,000 | New |
| Citadel Advisors LLC | 11,457 | $7.68K | 0.00% | −2,373−17.2% | Reduced |
| UBS Group AG | 125 | $83 | 0.00% | −1,709−93.2% | Reduced |